title: Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
authors.forename: Roland
authors.initials: R
authors.lastname: Fischer
authors.forename: Rainer
authors.initials: R
authors.lastname: Engelhardt
mesh_terms: D000818:Animals; D000077543:Deferiprone; D003676:Deferoxamine / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D011728:Pyridones / Q000627:therapeutic use*; D017086:beta-Thalassemia / Q000188:drug therapy*
chemical_list: D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D003676:Deferoxamine